What brexpiprazole brings to the treatments for schizophrenia in pediatric patients

Video

Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.

Contemporary Pediatrics sat down with Abigail Donovan, MD, assistant professor of psychiatry at Massachusetts General Hospital in Boston to discuss brexpiprazole, which recently received a supplemental new drug application from the US Fod and Drug Administration for use in patients aged 13 to 17 years. She discussed what it brings to the table, the adverse effects it can cause, and who is likely to prescribe it.

Related Videos
Steven Selbst, MD
Earls and Flower
Cassidy Foley Davelaar, DO, FAAP, CAQSM
Rupa Wong, MD | Image Credit: Rupa Wong, MD
James Wallace, MD | Image Credit: Provided by James Wallace, MD
James Wallace, MD | Image Credit: Provided by James Wallace, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
John Bradley, MD
Related Content
Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

December 9th 2023
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Addressing atypical anorexia: Part 3

Addressing atypical anorexia: Part 3

April 1st 2022
Podcast

The final episode in our podcast series on atypical anorexia discusses fat bias in health care and its impact on diagnosis and when pushback against diagnosis happens.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up | Image Credit: © syahrir - © syahrir - stock.adobe.com.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up

November 10th 2023
Article

The US approval makes VLA1553 (Ixchiq; Valneva) the world’s first licensed chikungunya vaccine.

Addressing atypical anorexia: Part 2

Addressing atypical anorexia: Part 2

March 11th 2022
Podcast

Dr. Erin Harrop discusses the necessity of understanding that eating disorders do not all look the same in every patient and how a multidisciplinary approach could be an effective way to diagnose and manage anorexia nervosa that is atypical.

Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis | Image Credit: © Calin- © Calin - stock.adobe.com.

Ustekinumab biosimilar approved for children 6 years and up with plaque psoriasis, psoriatic arthritis

November 7th 2023
Article

Ustekinumab-auub is approved to treat indications that are currently approved for ustekinumab, including moderate to severe plaque psoriasis (candidates for phototherapy or systemic therapy) and for those with active psoriatic arthritis, aged 6 years and older.

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Contemporary Pediatrics week in review: Infant mortality rates, FDA approvals, and more

November 3rd 2023
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

© 2023 MJH Life Sciences

All rights reserved.